| Literature DB >> 22243622 |
Carita Savolainen-Kopra1, Jaason Haapakoski, Piia A Peltola, Thedi Ziegler, Terttu Korpela, Pirjo Anttila, Ali Amiryousefi, Pentti Huovinen, Markku Huvinen, Heikki Noronen, Pia Riikkala, Merja Roivainen, Petri Ruutu, Juha Teirilä, Erkki Vartiainen, Tapani Hovi.
Abstract
BACKGROUND: Hand hygiene is considered as an important means of infection control. We explored whether guided hand hygiene together with transmission-limiting behaviour reduces infection episodes and lost days of work in a common work environment in an open cluster-randomized 3-arm intervention trial.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22243622 PMCID: PMC3296604 DOI: 10.1186/1745-6215-13-10
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279
Figure 1Trial design, recruitment and reporting.
Characteristics of the participants in different intervention arms.
| INTERVENTION ARM | N OF INITIAL PARTICIPANTS | AGE RANGE (STD) | MEAN AGE | PROPORTION OF THOSE WITH CHILDREN IN DAY CARE | MEAN OF RELATIVE RISK SUM |
|---|---|---|---|---|---|
| IR 1 | 257 | 22-64 (10.2) | 45.1 | 0.118 | 63.9 |
| IR2 | 202 | 20-63 (10.1) | 42.7 | 0.128 | 55.0 |
| CONTROL | 224 | 21-62 (11.1) | 42.8 | 0.144 | 59.9 |
Cluster characteristics, and outcome data from the total study period, weeks 7-74 (a total of 68 weeks), as well as from the first part of the study prior to the influenza A/H1N1 pandemic for the infection proportion (no. of infection episodes/reported weeks).
| Random. set and triplet | Arm and cluster code | Total staff number | Relative infection risk sum | Soap or disinfectant usage per participant | Number of reported weeks | Median coverage% of weeks | No. of infection episodes | Infection proportion, whole study | Infection proportion, before the pandemic | Sick leave proportion | Absence proportion | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I/A | IR2 12 | 160 | 35 | 52 | 5.3 | 2997 | 89.5 | 305 | 0.102 | 0.113 | 0.037 | 0.040 |
| IR1 16 | 100 | 39 | 48 | 7.5 | 2515 | 89.7 | 195 | 0.078 | 0.095 | 0.029 | 0.030 | |
| C 26 | 80 | 45 | 22 | nr | 1159 | 88.9 | 111 | 0.096 | 0.096 | 0.054 | 0.057 | |
| I/B | C 15 | 100 | 45 | 36 | nr | 1740 | 73.6 | 122 | 0.070 | 0.083 | 0.026 | 0.037 |
| IR2 14 | 100 | 47 | 12 | 15.8 | 648 | 76.9 | 72 | 0.111 | 0.111 | 0.045 | 0.057 | |
| IR1 13 | 160 | 50 | 57 | 9.2 | 3544 | 83.1 | 443 | 0.125 | 0.115 | 0.072 | 0.078 | |
| I/C | IR2 24 | 76 | 51 | 25 | 8.1 | 1537 | 89.1 | 263 | 0.171 | 0.170 | 0.034 | 0.051 |
| IR1 20 | 50 | 55 | 12 | 2.8 | 645 | 91.7 | 55 | 0.085 | 0.110 | 0.029 | 0.029 | |
| C 25 | 96 | 57 | 27 | nr | 1248 | 73.9 | 174 | 0.139 | 0.185 | 0.036 | 0.043 | |
| I/D | IR2 21 | 50 | 57 | 16 | 7.5 | 1132 | 86.4 | 102 | 0.090 | 0.087 | 0.027 | 0.034 |
| C 22 | 50 | 65 | 20 | nr | 1174 | 94.7 | 133 | 0.113 | 0.135 | 0.035 | 0.040 | |
| IR1 18 | 82 | 72 | 31 | 5.1 | 1807 | 96.3 | 131 | 0.072 | 0.061 | 0.031 | 0.032 | |
| II/A | IR2 6 | 118 | 41 | 37 | 5.4 | 2078 | 86.1 | 213 | 0.103 | 0.096 | 0.037 | 0.045 |
| C 3 | 150 | 50 | 50 | nr | 2690 | 89.2 | 313 | 0.116 | 0.127 | 0.031 | 0.037 | |
| IR1 10 | 123 | 58 | 54 | 3.9 | 3167 | 91.7 | 312 | 0.099 | 0.094 | 0.041 | 0.055 | |
| II/B | IR2 5 | 110 | 68 | 33 | 7.1 | 2079 | 97.1 | 194 | 0.093 | 0.080 | 0.031 | 0.047 |
| IR1 7 | 45 | 69 | 23 | 6.2 | 1370 | 91.3 | 105 | 0.077 | 0.075 | 0.034 | 0.039 | |
| C 2 | 150 | 70 | 33 | nr | 1841 | 88.1 | 184 | 0.100 | 0.095 | 0.037 | 0.043 | |
| II/C | IR2 9 | 100 | 86 | 27 | 6.3 | 1515 | 85.2 | 139 | 0.092 | 0.087 | 0.035 | 0.050 |
| C 8 | 160 | 87 | 36 | nr | 1792 | 82.4 | 177 | 0.099 | 0.096 | 0.033 | 0.041 | |
| IR1 4 | 80 | 104 | 32 | 1.3 | 1966 | 91.3 | 210 | 0.107 | 0.105 | 0.024 | 0.034 | |
| Total | IR1 | 640 | 903 | 257 | 6.1 | 15014 | 89.5 | 1451 | 0.097 | 0.037 | 0.043 | |
| IR2 | 714 | 774 | 202 | 6.9 | 11986 | 89.0 | 1288 | 0.107 | 0.035 | 0.046 | ||
| C | 786 | 851 | 224 | nr | 11644 | 83.8 | 1214 | 0.104 | 0.036 | 0.043 |
Totals in the three last lines were calculated from the cluster means.
Figure 2Reporting coverage in the study arms.
Outcome measures in different study periods.
| OUTCOME MEASURE | INTERVENTION ARM | BEFORE THE PANDEMIC | DURING AND AFTER THE PANDEMIC | TOTAL FOLLOW-UP TIME |
|---|---|---|---|---|
| IR1 | 0.097 | 0.097 (p = 0.04 vs. C) | ||
| IR2 | 0.108 | 0.107 | 0.107 | |
| CONTROL | 0.115 | 0.104 | ||
| IR1 | 0.078 | 0.076 | ||
| IR2 | 0.084 | 0.085 (p = 0.03 vs. C) | 0.085 | |
| CONTROL | 0.088 | 0.075 | 0.080 | |
| IR1 | 0.015 | 0.011 | ||
| IR2 | 0.017 | 0.015 | 0.016 | |
| CONTROL | 0.018 | 0.015 | 0.016 | |
| IR1 | 0.031 | 0.047 | 0.042 | |
| IR2 | 0.027 | 0.039 | 0.035 | |
| CONTROL | 0.030 | 0.038 (p = 0.003 vs. IR1) | 0.035 (p = 0.004 vs. IR1) | |
| IR1 | 0.038 | 0.054 | 0.048 | |
| IR2 | 0.036 | 0.050 | 0.045 | |
| CONTROL | 0.038 | 0.044 (p = 0.003 vs. IR1) | 0.042 (p = 0.009 vs. IR1) |
Numbers represent proportions calculated from the number of reported episodes in a trial arm per total reported weeks. Proportions can be converted to episodes per person year by multiplying by 52. Statistically significant differences indicating efficacy of the intervention are shown in bold face.
Figure 3a) Temporal distribution of all infection episodes/weekly reports in different intervention arms during the study. C, control arm; IR1, soap and water using arm; IR2, alcohol-based hand rub using arm. b) Respiratory viruses detected in the study between January 2009-May 2010. Influenza detections during November-December 2009 consist of pandemic influenza A/H1N1. Other viruses includes adenovirus (N = 1), respiratory syncytial virus (N = 1) and parainfluenzaviruses (N = 7), c) Respiratory virus findings reported to the National Infectious Disease Registry in Finland. Other virus includes adenovirus (N = 872), respiratory syncytial virus (N = 4048) and parainfluenzaviruses (N = 608).
Figure 4Results of the survey of behavioral habits. C, control arm; IR1, soap and water using arm; IR2, alcohol-based hand rub using arm. Results of January 2009 (yellow) represent baseline before any of the recruited office work employees had received guidance on hand hygiene.